Prévention des complications thromboemboliques des patients adultes porteurs de cardiopathie congénitale [Prevention of thromboembolic complications in adult congenital heart disease]
Fiche du document
25 mai 2022
- doi: 10.53738/REVMED.2022.18.783.1057
- issn: 1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2022.18.783.1057
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/35612479
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_1224D3719DB22
info:eu-repo/semantics/openAccess , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
Citer ce document
S. Oestreicher et al., « Prévention des complications thromboemboliques des patients adultes porteurs de cardiopathie congénitale [Prevention of thromboembolic complications in adult congenital heart disease] », Serveur académique Lausannois, ID : 10.53738/REVMED.2022.18.783.1057
Métriques
Partage / Export
Résumé
Thromboembolic complications in adults with congenital heart disease are frequent and responsible for significant morbidity and mortality. Their prevention frequently requires long-term thromboprophylaxis. In this article, we discuss the specificities that must be considered when stratifying the thromboembolic risk in these patients, the different therapeutic strategies, particularly the place of direct oral anticoagulants.